Newsletter | October 23, 2026

10.23.26 -- Advancing Cell Therapy Toward A Functional Cure For T1D

SPONSOR

On Demand Webinar: De-Risking Cell Culture Media Scale-Up for Late-Stage Manufacturing

Scaling cell culture media manufacturing from the lab to commercial production requires balancing performance, quality, and supply reliability. Join Thermo Fisher Scientific to explore practical strategies for successful scale-up, including supply assurance, granular media benefits, evolving QC requirements, digital formulation tools, and real-world case studies. Gain insights to improve efficiency, reduce risk, accelerate commercialization, and strengthen manufacturing readiness today. Click here to learn more.

How Modular Workflows Are Redefining CAR T Manufacturing

Webinar | Thermo Fisher Scientific

Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control.

 

Viral Safety Considerations In Process Development

Webinar | Cytiva

Explore how upstream media filtration and downstream anion exchange chromatography can work together to manage viral risk.

 

Advancing Cell Therapy Toward A Functional Cure For T1D

Video | Cell & Gene

On episode 139, Host Erin Harris talks to Jonathan Rigby, President and CEO of Sernova (and proposed CEO of BetaNova) and Will Rust, PhD, President and CEO of Seraxis (and proposed President and Chief Scientific Officer of BetaNova). Sernova and Seraxis are coming together to form BetaNova, combining Sernova’s implantable Cell Pouch with Seraxis’ stem cell-derived pancreatic islet cells in an effort to develop a functional cell therapy for people living with Type 1 diabetes (T1D).

The Next Evolution In Advanced Biomanufacturing

Video | Future Fields

How do we produce recombinant proteins in transgenic fruit flies? Matt Anderson-Baron, PhD, provides the deep-dive of an innovative, novel biomanufacturing process.

Autonomous Impinging Jet Mixing For LNP Process Development

Webinar | KNAUER

Discover how impinging jet mixing combined with automation and data-driven optimization offers a more systematic path to identifying process parameters for scalable, reproducible LNP manufacturing.

A Two-Step Approach Using A Mixed-Mode Resin For mAb Purification

Webinar | Bio-Rad Laboratories, Inc.

Streamlining downstream antibody purification to two steps reduces operating costs, processing time, and buffer use while achieving high monomer purity and aggregate clearance.

Connect With Bioprocess Online: